SCHEMBL1228339

SCHEMBL1228339

O=C1C=Cc2ccccc2SN1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.33
GAA P10253 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
BCHE P06276 1/20 0.33
POLB P06746 1/20 0.33
PTPRC P08575 1/20 0.33
THRB P10828 1/20 0.33
PKM P14618 1/20 0.33
IDO1 P14902 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
PTPN1 P18031 1/20 0.33
ACHE P22303 1/20 0.33
CES1 P23141 1/20 0.33
RECQL P46063 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7853152 0.76 GAA (0.31) MAPTGAA
SCHEMBL7855328 0.75 GAA (0.33) MAPTGAA
SCHEMBL5048603 0.67 GSK3B (0.61) MAPTGAAKDM4EMEN1ALDH1A1
SCHEMBL10783521 0.67 GSK3B (0.61) MAPTGAAKDM4EMEN1ALDH1A1
SCHEMBL3081408 0.67 GPR84 (0.33) MAPTGAAMEN1BCHEPOLB
SCHEMBL8274 0.67 PARP1 (0.34) MAPTGAAMEN1BCHEPOLB
SCHEMBL5686105 0.67 PARP1 (0.34) MAPTGAAMEN1BCHEPOLB
SCHEMBL6111542 0.67 L3MBTL1 (0.30)
Formaldehyde SCHEMBL28424513 0.67 PARP1 (0.31)
SCHEMBL4742301 0.66 TRPA1 (0.50) MAPTGAAKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757558-A4 SCREENING METHODS FOR INTEGUMENTAL INFLAMMATION MODULATING AGENTS ALZA CORP (US) 1999-06-16 EP claimed
EP-0757558-A1 SCREENING METHODS FOR INTEGUMENTAL INFLAMMATION MODULATING AGENTS ALZA CORPORATION (US) 1997-02-12 EP claimed
WO-1995027510-A1 SCREENING METHODS FOR INTEGUMENTAL INFLAMMATION MODULATING AGENTS ALZA CORPORATION (US) 1995-10-19 WO claimed
EP-0462696-B1 Novel pyrido [2,3-f][1,4] thiazepines and pyrido [3,2-b][1,5] benzothiazepines ORTHO PHARMA CORP (US) 1995-08-09 EP claimed
EP-0526495-A1 1,5-BENZOTHIAZEPINONE DERIVATIVES, THEIR PREPARATIONS AND PHARMACEUTICAL USE ISTITUTO LUSO FARMACO D'ITALIA S.p.A. (IT) 1993-02-10 EP claimed
EP-0462696-A1 Novel pyrido [2,3-f][1,4] thiazepines and pyrido [3,2-b][1,5] benzothiazepines ORTHO PHARMACEUTICAL CORPORATION (US) 1991-12-27 EP claimed
EP-0324181-B1 PROCESS FOR THE PREPARATION OF BENZOTHIAZEPINONE DERIVATIVES BAYER AG (DE) 1991-11-27 EP claimed
WO-1991017153-A1 1,5-BENZOTHIAZEPINONE DERIVATIVES, THEIR PREPARATIONS AND PHARMACEUTICAL USE ISTITUTO LUSO FARMACO D'ITALIA S.P.A. (IT) 1991-11-14 WO claimed
EP-0242265-B1 1,5-BENZOTHIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTICAL USE SYNTHELABO (FR) 1991-05-29 EP claimed
US-4948886-A Process for the preparation of benzothiazepinone derivatives BAYER AKTIENGESELLSCHAFT (DE) 1990-08-14 US claimed
EP-0324181-A1 Process for the preparation of benzothiazepinone derivatives BAYER AG (DE) 1989-07-19 EP claimed
EP-0320361-A1 3-Hydroxy-2-(4-methoxyphenyl)-5(2-methylaminoethyl)-2,3-dihydro-5H-1,5-benzothiazepin-4-one derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1989-06-14 EP claimed
EP-0242265-A1 1,5-Benzothiazepine derivatives, their preparation and their therapeutical use SYNTHELABO (FR) 1987-10-21 EP claimed
JP-2145564-A None JP disclosed
US-12454502-B2 Synthesis of deuterated aldehydes ARIZONA BOARD OF REGENTS ON BEHALF OF ATHE UNIVERSITY OF ARIZONA (US) 2025-10-28 US disclosed
CN-115990258-A Use of GSK 3beta inhibitor in treating primary immune thrombocytopenia 复旦大学附属金山医院(上海市金山区眼病防治所、上海市金山区核化伤害应急救治中心) 2023-04-21 CN disclosed
EP-0267924-A1 NITRIC ESTERS OF BENZOTHIAZEPINONES BAUDET, Pierre (CH) 1988-05-25 EP disclosed
US-4743599-A CALCIUM ANTAGONIST, CARDIOVASCULAR DISORDERS SYNTHELABO (FR) 1988-05-10 US disclosed
WO-1987006934-A1 NITRIC ESTERS OF BENZOTHIAZEPINONES BAUDET PIERRE (CH) 1987-11-19 WO disclosed
EP-0242265-A1 1,5-Benzothiazepine derivatives, their preparation and their therapeutical use SYNTHELABO (FR) 1987-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12454502-B2 Synthesis of deuterated aldehydes ADH1C, ADH1A, CBR1 MAPT 4584/4885GAA 1604/4885KDM4E 2477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.